Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase I trial of vatalanib (PTK/ZK) in combination with bevacizumab in patients with refractory and/or advanced malignancies.
Jones SF, Spigel DR, Yardley DA, Thompson DF, Burris HA 3rd. Jones SF, et al. Among authors: yardley da. Clin Adv Hematol Oncol. 2011 Nov;9(11):845-52. Clin Adv Hematol Oncol. 2011. PMID: 22252616 Clinical Trial.
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
Rosenthal DI, Lee JH, Sinard R, Yardley DA, Machtay M, Rosen DM, Egorin MJ, Weber RS, Weinstein GS, Chalian AA, Miller LK, Frenkel EP, Carbone DP. Rosenthal DI, et al. Among authors: yardley da. J Clin Oncol. 2001 Mar 1;19(5):1363-73. doi: 10.1200/JCO.2001.19.5.1363. J Clin Oncol. 2001. PMID: 11230480 Clinical Trial.
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.
Hainsworth JD, Burris HA 3rd, Yardley DA, Bradof JE, Grimaldi M, Kalman LA, Sullivan T, Baker M, Erland JB, Greco FA. Hainsworth JD, et al. Among authors: yardley da. J Clin Oncol. 2001 Aug 1;19(15):3500-5. doi: 10.1200/JCO.2001.19.15.3500. J Clin Oncol. 2001. PMID: 11481356 Clinical Trial.
Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA 3rd, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA. Hainsworth JD, et al. Among authors: yardley da. Cancer J. 2002 Jul-Aug;8(4):311-21. doi: 10.1097/00130404-200207000-00007. Cancer J. 2002. PMID: 12184409 Clinical Trial.
Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.
Hainsworth JD, Litchy S, Burris HA 3rd, Scullin DC Jr, Corso SW, Yardley DA, Morrissey L, Greco FA. Hainsworth JD, et al. Among authors: yardley da. J Clin Oncol. 2002 Oct 15;20(20):4261-7. doi: 10.1200/JCO.2002.08.674. J Clin Oncol. 2002. PMID: 12377971 Clinical Trial.
Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Jones SF, Burris HA 3rd, Hainsworth JD, Yardley DA, Raefsky EA, Miranda FT, Kuzur ME, Willcutt NT, White MB, Greco FA. Jones SF, et al. Among authors: yardley da. Oncology (Williston Park). 2003 May;17(5 Suppl 5):36-40. Oncology (Williston Park). 2003. PMID: 12800605 Review.
Gemcitabine and taxanes as a new standard of care in breast cancer.
Yardley DA. Yardley DA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S107-12. doi: 10.3816/cbc.2004.s.003. Clin Breast Cancer. 2004. PMID: 14754467 Review.
Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
Burris H 3rd, Yardley D, Jones S, Houston G, Broome C, Thompson D, Greco FA, White M, Hainsworth J. Burris H 3rd, et al. Among authors: yardley d. J Clin Oncol. 2004 May 1;22(9):1621-9. doi: 10.1200/JCO.2004.08.065. J Clin Oncol. 2004. PMID: 15117984 Clinical Trial.
Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer.
Yardley DA. Yardley DA. Semin Oncol. 2004 Apr;31(2 Suppl 5):37-44. doi: 10.1053/j.seminoncol.2004.03.026. Semin Oncol. 2004. PMID: 15199531 Review.
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S, Yardley DA, Burris HA 3rd, Morrissey LH, Erland JB, Hainsworth JD. Greco FA, et al. Among authors: yardley da. Oncologist. 2004;9(6):644-52. doi: 10.1634/theoncologist.9-6-644. Oncologist. 2004. PMID: 15561808 Clinical Trial.
127 results
Jump to page
Feedback